Literature DB >> 22552858

Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?

Ennio Lubrano1, Antonio Spadaro.   

Abstract

This article summarizes the state of the art of axial involvement in psoriatic arthritis (axial PsA). The definition and measurement of axial disease in PsA still remain problematic, and this, in turn, could affect the best approach of recognition and treatment of this intriguing subset of the psoriatic disease. Axial PsA has been studied over the last few years looking at the difference in function and radiological finding compared to ankylosing spondylitis (AS), trying to differentiate it from a coincidental AS with psoriasis. Finally, this review has described the diagnosis and treatment of axial PsA reporting the data obtained from the literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552858     DOI: 10.1007/s10067-012-1990-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  40 in total

1.  Axial psoriatic arthritis: update on a longterm prospective study.

Authors:  Vinod Chandran; Jessica Barrett; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Journal:  J Rheumatol       Date:  2009-11-02       Impact factor: 4.666

2.  The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods.

Authors:  E Lubrano; A Marchesoni; I Olivieri; S D'Angelo; A Spadaro; W J Parsons; A Cauli; C Salvarani; A Mathieu; E Zaccara; N Ferrara; P S Helliwell
Journal:  Clin Exp Rheumatol       Date:  2009 Nov-Dec       Impact factor: 4.473

3.  Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes.

Authors:  X Baraliakos; J Listing; M Rudwaleit; H Haibel; J Brandt; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

4.  Consensus on a core set of domains for psoriatic arthritis.

Authors:  Dafna D Gladman; Philip J Mease; Vibeke Strand; Paul Healy; Philip S Helliwell; Oliver Fitzgerald; Alice B Gottlieb; Gerald G Krueger; Peter Nash; Christopher T Ritchlin; William Taylor; Ade Adebajo; Jurgen Braun; Alberto Cauli; Sueli Carneiro; Ernst Choy; Ben Dijkmans; Luiz Espinoza; Desiree van der Heijde; Elaine Husni; Ennio Lubrano; Dennis McGonagle; Abrar Qureshi; Enrique R Soriano; Jane Zochling
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

5.  Outcome measures in psoriatic arthritis.

Authors:  Dafna D Gladman; Philip J Mease; Paul Healy; Philip S Helliwell; Oliver Fitzgerald; Alberto Cauli; Ennio Lubrano; Gerald G Krueger; Désirée van der Heijde; Douglas J Veale; Arthur Kavanaugh; Peter Nash; Christopher Ritchlin; William Taylor; Vibeke Strand
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

6.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

7.  Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?

Authors:  William J Taylor; Andrew A Harrison
Journal:  Arthritis Rheum       Date:  2004-06-15

8.  Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study.

Authors:  D D Gladman; B Brubacher; D Buskila; P Langevitz; V T Farewell
Journal:  Clin Invest Med       Date:  1992-08       Impact factor: 0.825

9.  Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Authors:  J Brandt; A Khariouzov; J Listing; H Haibel; H Sörensen; L Grassnickel; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2003-06

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more
  5 in total

Review 1.  Looking into the new ASAS classification criteria for axial spondyloarthritis through the other side of the glass.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  Prevalence of chronic axial pain, inflammatory back pain, and spondyloarthritis in diagnosed psoriasis.

Authors:  Nicole Thom; Christopher T Ritchlin; Xiao Zhang; John Reveille; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 3.  ASAS classification criteria for axial spondyloarthritis: time to modify.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Clin Rheumatol       Date:  2016-04-19       Impact factor: 2.980

4.  Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.

Authors:  Ennio Lubrano; Antonio Spadaro
Journal:  BMC Musculoskelet Disord       Date:  2014-01-20       Impact factor: 2.362

Review 5.  Evaluating Inflammatory Versus Mechanical Back Pain in Individuals with Psoriatic Arthritis: A Review of the Literature.

Authors:  Linda L Grinnell-Merrick; Eileen J Lydon; Amanda M Mixon; William Saalfeld
Journal:  Rheumatol Ther       Date:  2020-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.